Anti-LRRFIP2 antibodies are used in the immunodetection of the protein LRR binding FLII interacting protein 2. In humans, the canonical protein has a reported length of 721 amino acid residues and a mass of 82.2 kDa. Up to 5 different isoforms have been reported for this protein. It is found to be widely expressed, with highest levels in the heart and skeletal muscle. A member of the LRRFIP protein family, LRRFIP2 is believed to function as a activator of the canonical Wnt signaling pathway, in association with DVL3, upstream of CTNNB1/beta-catenin. Synonyms for this target antigen include leucine-rich repeat flightless-interacting protein 2, LRR FLII-interacting protein 2, leucine rich repeat (in FLII) interacting protein 2, and HUFI-2. LRRFIP2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Western Blot is the most common application for the LRRFIP2 antibodies listed below. Immunofluorescence and Immunohistochemistry are also common applications.